Treatment of human acute schistosomiasis with oxamniquine induces an increase in interferon-g response to Schistosoma mansoni antigens Joelma R de Souza; Clarice NL Morais; Marcílio L Aroucha; Paulo JC Miranda; Constança S Barbosa, Ana Lúcia C Domingues; Luiz B Carvalho Júnior; Frederico GC Abath; Silvia ML Montenegro PAGE: 225-228 | DOI: 10.1590/S0074-02762007005000002

The schistosome enzyme that activates oxamniquine has the characteristics of a sulfotransferase Livia Pica-Mattoccia; Daniele Carlini; Alessandra Guidi; Velasco Cimica; Fabio Vigorosi; Donato Cioli PAGE: 307-312 | DOI: 10.1590/S0074-02762006000900048

Schistogram changes after administration of antischistosomal drugs in mice at the early phase of Schistosoma mansoni infection Andréa Cássia Simões Vimieiro, Neusa Araújo, Naftale Katz, John Robert Kusel, Paulo Marcos Zech Coelho PAGE: 881-886 | DOI: 10.1590/0074-0276130135

Altered Response of Strain of Schistosoma mansoni to Oxamniquine and Praziquantel Patrícia Ivana Pires Bonesso-Sabadini, Luiz Cândido de Souza Dias PAGE: 381-385

Study of Schistosoma mansoni Isolates from Patients with Failure of Treatment with Oxamniquine Maria José Conceição, Carlos Alberto Argento, Acyr Corrêa PAGE: 375-380

Activity of Oxamniquine at Skin, Pulmonary and Sexual Maturation Phases, on a Schistosoma mansoni Strain (R1) Previously Reported as Resistant at the Adult Phase Paulo Marcos Z Coelho*/**/, Fábio Ribeiro*, Rômulo T Mello, Francisco C Lima e Silva**, José Augusto Nogueira-Machado** PAGE: 267-268